2024 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
51.5 M |
136.2 % |
2023 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
21.8 M |
- |
2022 |
Genmab - ADR
|
- |
19 M |
- |
2022 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
- |
- |
2021 |
Genmab - ADR
|
- |
16.6 M |
43.1 % |
2021 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
- |
- |
2020 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
11.6 M |
- |
2019 |
Genmab - ADR
|
Executive Vice President and Chief Operating Officer |
- |
- |